Riskpilot← Back to searchSign inGet full accessHeraeus Medical AB
ABActiveOrg 5565505889Vasagatan 28 7trWholesale of pharmaceutical and medical goods · NACE 4646Est. 19975-9 employees
Revenue 2024
SEK 56,3M
+1% vs 2023
EBITDA margin
4.3%
0% vs 2023
Equity ratio
44.5%
Financial strength
Net profit 2024
SEK 2,2M
-5% vs 2023
| Revenue | SEK 56,3M | +1% |
| EBITDA | SEK 2,4M | +0% |
| Net profit | SEK 2,2M | -5% |
| Total assets | SEK 24,7M | +23% |
| Equity | SEK 11M | +16% |
| Employees | — | — |
Legal name
Heraeus Medical AB
Org number
5565505889
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
30 december 1997
Share capital
SEK 400 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av Norrbin, Eva Birgitta i förening med ledamoten suppleanten
Company purpose
Bolaget ska bedriva tillverkning och försäljning av medicinska produkter, tillhandahålla medicinska tjänster samt bedriva därmed förenlig verksamhet.
Address
Vasagatan 28 7tr
Phone
+46858577756
Email
eva.norrbin@heraeus.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 37 648 | 39 262 | 47 140 | 55 532 | 56 277 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 074 | 1 839 | 1 846 | 2 414 | 2 423 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 1 074 | 1 839 | 1 846 | 2 414 | 2 423 |
| Net financials | −11 | −5 | 3 | −18 | −55 |
| Profit before tax | 947 | 1 677 | 2 177 | 2 947 | 2 816 |
| Tax | −237 | −381 | −495 | −654 | −631 |
| Net profit | 710 | 1 296 | 1 682 | 2 293 | 2 185 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 16 984 | 19 045 | 19 305 | 20 019 | 24 666 |
| Equity | 5 431 | 6 726 | 7 908 | 9 500 | 10 985 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 8 996 | 9 604 | 9 009 | 8 682 | 12 292 |
| Total debt | 8 996 | 9 604 | 9 009 | 8 682 | 12 292 |
EBITDA margin
4.3%
This company
15.8%
Market median
-73% vs market
20202024
Equity ratio
44.5%
This company
38.2%
Market median
+16% vs market
20202024
Return on equity
19.9%
This company
18.4%
Market median
+8% vs market
20202024
Net profit margin
3.9%
This company
8.1%
Market median
-52% vs market
20202024
Asset turnover
2.28×
This company
1.12×
Market median
+104% vs market
20202024
Debt / equity
1.25×
This company
0.62×
Market median
-102% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
EB External Signatory | External Signatory | 2021 |
KE Chief Auditor | Chief Auditor | 2023 |
| Former (3) | ||
PN Chief Auditor | Chief Auditor | 2022 – 2023 |
CE Chief Auditor | Chief Auditor | 2021 – 2022 |
JO Chief Auditor | Chief Auditor | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
| Former (1) | ||
| Chairman | 2021 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HERAEUS BETEILIGUNGSGESELLSCHAFT MBH
Heraeus Medical AB (this company)Board members of Heraeus Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pontus Niclas Roland Ekevid | Chief Auditor | 0 companies |
| Eva Birgitta Norrbin | External Signatory | 0 companies |
| Knut Erik Theodor Heilborn | Chief Auditor | 0 companies |
| Camilla Elsa Ingegerd Ral Ingvarson | Chief Auditor | 0 companies |
| Jens Oscar Simon Bertling | Chief Auditor | 0 companies |
| Ulrike Voss | Deputy Board Member | 0 companies |
| Steffen Ellermann | Board of Directors | 0 companies |
| Nicole Petermann | Chairman | 0 companies |